银屑病关节炎发作的发病率、定义及危险因素:一项系统综述
该系统综述检索至2023年9月,纳入54项队列、横断面和临床试验研究,评估银屑病关节炎发作的发病率、定义标准及相关危险因素。基于高质量评分,当前发作患病率为7%至10%,年发病率为22%至23%;44项研究定义了发作但无统一标准,危险因素证据有限或不清楚。
要点
- 基于高质量评分,当前患者报告的发作患病率为10%,医生报告的发作患病率为7%,12个月发作发病率为22%至23%。
- 发作定义标准可归为七类,常用疾病活动度评分(36%)、患者报告(39%)、医生报告(30%)和改变治疗(25%)。
- 危险因素证据有限或不清楚,无法得出结论,需进一步研究。
核心结论
- 基于高质量评分,当前发作患病率范围为7%至10%,年发病率为22%至23%。
- 44项研究定义了发作,但未就单一发作定义达成共识,凸显需要标准化定义。
- 无法就危险因素得出结论,凸显需要进一步研究。
研究设计与样本
- 系统综述检索Embase、Medline ALL、Web of Science核心合集和Cochrane对照试验中心注册库至2023年9月,纳入研究银屑病关节炎发作的原创文章。
- 共纳入54项队列、横断面和临床试验设计的研究,使用纽卡斯尔-渥太华量表评估纳入研究质量。
主要发现
- 12项研究评估发作率,28项评估危险因素,44项定义发作。
- 当前发作患病率范围为7%至50%(n=8),6个月发作发病率范围为10%至27%(n=3),12个月发作发病率范围为22%至23%(n=2)。
- 基于高质量评分,当前患者报告的发作患病率为10%(n=1),当前医生报告的发作患病率为7%,12个月发作发病率为22%至23%(n=2)。
- 发作定义标准可归为七类,疾病活动度评分(36%)、患者报告(39%)、医生报告(30%)和改变治疗(25%)为常用标准。
- 危险因素可归为四类:关节炎治疗、SARS-CoV、银屑病关节炎特征和其他;这些因素的证据有限或不清楚。
关键数值与推荐
- 当前发作患病率范围为7%至50%(n=8)。
- 6个月发作发病率范围为10%至27%(n=3)。
- 12个月发作发病率范围为22%至23%(n=2)。
- 基于高质量评分,当前患者报告的发作患病率为10%(n=1),当前医生报告的发作患病率为7%,12个月发作发病率为22%至23%(n=2)。
- 发作定义中使用疾病活动度评分占36%、患者报告占39%、医生报告占30%、改变治疗占25%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 危险因素证据有限或不清楚,无法就危险因素得出结论。
- 未就单一发作定义达成共识。
- 需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We systematically reviewed the literature to identify the incidence of PsA flare, criteria used to define it and associated risk factors. METHODS: Databases of Embase, Medline ALL, Web of Science Core Collection and Cochrane Central Register of Controlled Trials were searched until September 2023, for original articles studying PsA flare. The Newcastle-Ottawa scale was used to assess the quality of included studies. RESULTS: Fifty-four studies of cohort, cross-sectional and clinical trial designs were included. Twelve studies assessed PsA flare rates, 28 assessed risk factors and 44 defined flare. The prevalence of current flare ranged between 7% and 50% (n = 8), while the incidence ranged between 10% and 27% over 6 months (n = 3), and 22% and 23% over 12 months (n = 2). Based on high-quality scoring, the current patient-reported flare was 10% (n = 1), while current physician-reported flare was 7% with 22-23% incidence rate over 12 months (n = 2). Criteria used in flare definition could be grouped into seven categories, with disease activity scores (36%), patient-reported (39%) and physician-reported (30%) flare and change in therapy (25%) being frequently used. Risk factors could be grouped into four categories: arthritis therapies, SARS-CoV, PsA features and other. The factors showed limited or unclear evidence. CONCLUSION: The current prevalence of flare ranged between 7% and 10%, and the annual incidence was 22-23%, based on high-quality scoring. Forty-four studies defined flare, revealing no consensus on a single flare definition, and highlighting the need for a standardized definition. No conclusions could be drawn on risk factors, highlighting the need for further research. PROSPERO REGISTRATION: CRD42024482657.
引用
- Hojeij B, Koc GH, Luime JJ, et al. Psoriatic arthritis flare incidence, definition and risk factors: a systematic review. Rheumatology (Oxford). 2025. PMID: 40392198. doi:10.1093/rheumatology/keaf247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。